Herpesvirus infections of the vulva

Seminars in Dermatology

Volumn 15, Issue 1, 1996, Pages 8-16

  Nader, Sonia N ^a   Prober, Charles G ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; HERPES SIMPLEX VACCINE; IMMUNOGLOBULIN M ANTIBODY; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

CLINICAL FEATURE; CLINICAL TRIAL; FEMALE; GENITAL HERPES; HERPES LABIALIS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HERPES VIRUS INFECTION; HUMAN; IMMUNE RESPONSE; INFECTION PREVENTION; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PREVALENCE; RECURRENT DISEASE; REVIEW; SERODIAGNOSIS; SEXUAL TRANSMISSION; TOPICAL DRUG ADMINISTRATION; VIRUS ISOLATION; VIRUS PATHOGENESIS; VULVA DISEASE; VULVOVAGINITIS;

EID: 0029924988     PISSN: 0278145X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1085-5629(96)80013-7     Document Type: Review

References (75)

1. Genital herpes infections United States 1966-1984. MMWR 35:402-404, 1986
2. Decker TM, Blount JH, Guinan M, et al: Genital herpes infections in private practice in the United States 1966-1981. JAMA 253:1601-1603, 1985
3. Sullivan BJ: Neonatal herpes simplex virus infections in King County, Washington. Increasing incidence and epidemiologic correlations. JAMA 256:3059-3062, 1983
4. Nader SN, Prober CG: Herpesvirus infections of the vulva and vagina, in Elsner P, Martius J (eds): Vulvovaginitis. New York, NY, Dekker, 1993, pp 229-273
5. Hill TJ: Herpes simplex virus, in Roizman B (ed): The Herpesviruses, vol 3. New York, NY, Plenum, 1985
6. Klein RJ, Friedman-Kien AE, DeStefano E: Latent herpes simplex virus infections in sensory ganglia of hairless mice prevented by acycloguanosine. Antimicrob Agents Chemother 15:723-729, 1979
7. Stanberry LR, Kern ER, Richards JT, et al: Genital herpes in guinea pigs: Pathogenesis of primary infection and description of recurrent disease. J Infect Dis 146:397-404, 1983
8. Stanberry LR: Capsaicin interferes with centrifugal spread of virus in primary and recurrent genital herpes simplex virus infection. J Infect Dis 162:29-34, 1990
9. Reeves WC, Corey L, Adams HG, et al: Risk of recurrence after first episode of genital herpes: Relation to HSV type and antibody response. N Engl J Med 305:315-319, 1981
10. Lafferty WE, Coombs RW, Benedetti J, et al: Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type. N Engl J Med 316:1444-1449, 1987
11. Klrin R: Reinfections at site specific immunity in herpes simplex virus infection. Vaccine 7:380-381, 1989
12. Buchman TG, Roizman B, Nahmias AJ: Demonstration of exogenous genital reinfection with herpes simplex virus type 2 by restriction endonuclease fingerprinting of viral DNA. J Infect Dis 140:295-304, 1979
13. Heller M, Dix RD, Baringer JR, et al: Herpetic proctitis and meningitis: Recovery of two strains of herpes simplex virus type 1 from cerebrospinal fluid. J Infect Dis 146:584-588, 1982
14. Mertz G, Ashley R: Double blind placebo controled trial at HSV type 2 glycoprotein vaccine in persons at high risk for genital herpes infection. J Infect Dis 1161:653-660, 1990
15. Nahmias AG, Josey WE: Epidemiology of herpes simplex viruses 1 and 2, in Evans AS (ed): Viral Infections of Humans. Epidemiology and Incidence. New York, NY, Plenum, 1982, pp 351-372
16. Whitley R: Herpes Simplex Viruses, in Fields BN, Knipe DM, et al (eds): Virology (ed 2). New York, NY, Raven, 1990, chap 66, p 1843
17. Holzel A, Feldman GV, Tobin JO, et al: Herpes simplex: A study of complement fixing antibodies at different ages. Acta Paediatr Scand 42:206, 1953
18. Wentworth BB, Alexander ER: Seroepidemiology of infections due to members of the herpesvirus group. Am J Epidemiol 94:496-507, 1971
19. Glezen WP, Fernal GW, Lohr JA: Acute respiratory disease of university students with special reference to the etiologic role of herpesvirus hominis. Am J Epidemiol 101:111-121, 1975
20. Smith IW, Peutherer JR, MacCallum FO: The incidence of herpesvirus hominis antibody in the population. J Hyg Camb 65:395-408, 1967
21. Kohl S: Postnatal Herpes Simplex Virus Infections, In Textbook of Pediatrid Infectious Diseases (ed 2). Feigin and Cherry, 1987, Vol II S77
22. Chuang TY, Su WP, Perry HO, et al: Incidence and trend of herpes progenitalis. A 15-year population study. Mayo Clin Proc 58:436-441, 1983
23. Prober CG, Arvin AM: Genital herpes and the pregnant woman. Remington and Schwartz; Curr Clin Topics Infectious Dis 10:1-26, 1989
24. Mertz G: Herpes simplex virus, in Galasso G, Whitely R, Merigan T (eds): Antiviral Agents and Viral Diseases in Man (ed 3). New York, NY, Raven, 1990
25. Koutsky L, Ashley R, et al: The frequency of unrecognized type 2 herpes simplex virus infection among women. Sexually Transmitted Diseases 17:2:90-94, 1990
26. Breinig MK, Kingsley LA: Epidemiology of genital herpes in Pittsburgh: Serologic, Sexual, and Racial Correlations of Apparent and In Apparent Herpes Simplex Infection. J Infect Dis 162:299-305, 1990
27. Nahmias AJ, Keyserling H, Bain R: Prevalence of herpes simplex virus (HSV) type-specific antibodies in a U.S.A. prepaid group medical practice population. Abstract, 6th International Meeting of the International Society for STD Research, Brighton, England, 1985
28. Johnson R, Nahmias A, Magder L, et al: A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States. N Engl J Med 321:7-12, 1989
29. Frenkel I, Shen JP, Garratty E, et al: A prospective study of pregnant women to determine the prevelance and risk factors of asymptomatic infection with HSV-2. Abstract, 1987, American Pediatric Society for Pediatric Research
30. Gibson J, Hornung C, et al: A cross-sectional study of herpes simplex virus types 1 and 2 in college students: Occurrence and determinants of infection. J Infect Dis 162:306-312, 1990
31. Bonchet F, Yasukawa I, Bronzan R, et al: A prospective evaluation of primary genital HSV2 infection acquired during pregnancy. Ped Inf Dis 9:499-504, 1990
32. Schmid D, Brown D, Sanchez-Martinez D, et al: Seroepidemiology of HSV2 infection in Randomly-sampled multiethnic neighborhoods in San Francisco. Abstract 5B-08, July 1991, XVI International Herpes Virus Workshop Asilomar
33. Soroush V, Kulhanjian J, Bronzan, et al: Identification of pregnant women at risk for primary genital HSV-2 infections through serologic evaluations of couples. Abstract 5B-04, July 1991, XVI International Herpes Virus Workshop Asilomar
34. Reeves W, Schmid D, Brown D, et al: Seroepidemiology of HSV-2 infection in rural Latin American populations. Abstract July 1991, XVI International Herpes Virus Workshop Asilomar
35. Corey L: Genital herpes in Holms K, Mardh P (eds): Sexually Transmitted Diseases (ed 2). New York, NY, Raven, 1990, chap 35, p 391
36. Mertz GJ, Schmidt O, Ashley, et al: Frequency of acquisition of first episode of genital infection with herpes simplex virus from symptomatic and asymptomatic contacts. Sexually Transmitted Diseases 12;1:83-89, 1985
37. Rooney JF, Felser JM, Ostrave J, et al: Acquisition of genital herpes from an asymptomatic sexual partner. N Engl J Med 314:1561-1564, 1986
38. Mertz GJ, Coombs RW, et al: Transmission of genital herpes in couples with one symptomatic and one asymptomatic partner: a prospective study. J Infect Dis 157:1169-1177, 1988
39. Corey L, Adams HG, Brown ZA, et al: Genital herpes simplex virus infections: Clinical manifestations, course, and complications. Ann Intern Med 98:958-972, 1983
40. Walzman M, Wade H: Labial adhesions after genital herpes infection. Genitourinary Med 65:187-188, 1989
41. De Marco BJ, Crandall RS, et al: Labial agglutination secondary to an herpes simplex II infection. Am J Gynecol 157:296-297, 1987
42. Bergstrom T, Vahlne A: Primary and recurrent herpes simplex virus type 2-induced meningitis. J Infect Dis 162:322-330, 1990
43. Corey L, King K, Holms K, et al: Genital Herpes Simplex Virus Infections: Current Concepts in Diagnosis, Therapy, and Prevention. Ann Inter Med 98:973-983, 1983
44. Joseph TJ, Vogt PJ: Disseminated herpes with hypoadrenal necrosis in an adult. Am J Med 56:735, 1974
45. Nahmias AJ: Disseminated herpes simplex virus infections. N Engl J Med 282:684, 1970
46. White WB, Hannah M, et al: Systemic herpes simplex virus type 2 infection. Arch Inter Med 144:826-827, 1984
47. Guinan ME, MacCalman J, et al: The course of untreated recurrent genital herpes simplex infection in 27 women. N Engl J Med 304:759-763, 1982
48. Mindel A, Coker D, et al: Recurrent genital herpes: Clinical and virological features in men and women. Genitourin Med 164:103-106, 1988
49. Borck B, Selk S, Benedetti J, et al: Frequency of asymptomatic shedding of herpes simplex virus in women with genital herpes. JAMA 19:263:418-420, 1990
50. Kreiss J, Koech D, Plummer F, et al: AIDS virus infection in Nairobi prostitutes. N Engl J Med 314:414-418, 1986
51. Quinn T, Mann J, Curran P, et al: AIDS in Africa: An epidemiologic paradigm. Science 234:955-963, 1986
52. Stamm W, Handsfield H, Rampolo A, et al: The association between genital ulcer diseases and acquisition of HIV infection in homosexual men. JAMA 260:1429-1433, 1988
53. Holmberg S, Stewart J, Gerber R, et al: Prior herpes simplex virus type 2 infection as a risk factor for HIV infection. JAMA 259:1048-1050, 1988
54. Arvin A, Prober CG: Herpes simplex viruses, in Balow A (ed): Manual of Clinical Microbiology (ed 5). ASM Press, 1990, chap 75
55. Yeager A, Morris J, Prober C, et al: Storage and transport of cultures for herpes simplex virus, type 2. Am J Clin Pathol 72:977-979, 1979
56. Yeager AS, Arvin AM, Hensleigh PA: The validity of reporting results for herpes simplex virus after four days. J Reprod Med 27:447-448, 1982
57. Moseley RC, Corey L, Benjamin D, et al: Comparison of viral isolation, direct immunofluorescence, and indirect immunoperoxidase techniques for detection of genital herpes simplex virus infection. J Clin Microbiol 13:913-918, 1981
58. Arvin AM, Hensleigh PA, Prober CG, et al: Failure of antepartum maternal cultures to predict the infant's risk of exposure to herpes simplex virus at delivery. N Engl J Med 315:796-800, 1986
59. Salonen AR, Rasmussenf E, et al: The Tzank smear in the diagnosis of cutaneous herpes simplex. JAMA 251:633-636, 1984
60. Sullender WM, Yasukawa LL, Schwartz M, et al: Type-specific antibodies to herpes simplex virus type 2 (HSV-2) glycoprotein G in pregnant women, infants exposed to maternal HSV-2 infections at delivery, and infants with neonatal herpes. J Infect Dis 157:164-171, 1988
61. Coleman RM, Pereira L, Baily PD, et al: Determination of herpes simplex virus type specific antibodies by enzyme linked immunosorbent assay. J Clin Microbiol 18:287-289, 1983
62. Corey J, Benedetti J, Cricthlow C, et al: Treatment of primary first episode genital HSV infections with acyclovir: Results of topical, intravenous acyclovir for the treatment of primary genital herpes. J Anti Microb Chemo 12(B)79, 1983
63. Corey L, Fife KH, Benedetti JK, et al: Intravenous acyclovir for the treatment of primary genital herpes. Ann Intern Med 98:914, 1983
64. Corey L, Nahmias AJ, Guinan ME, et al: A trial of topical acyclovir in genital herpes simplex virus infections. N Engl J Med 306:1313, 1982
65. Mertz GJ, Reichman R, Dolin R, et al: Double blind placebo-controlled trial of oral acyclovir for first episode genital herpes. JAMA 252:1147, 1984
66. Mindel A, Adler MW, Sutherland S, et al: Intravenous acyclovir treatment for primary genital herpes. Lancet 1:697, 1982
67. Nilsen AE, Aesen T, Halsos AM, et al: Efficacy of oral acyclovir in the treatment of initial and recurrent genital herpes. Lancet 2:571, 1982
68. Reichman RC, Badger CJ, Mertz GJ, et al: Treatment of recurrent genital herpes simplex infections with oral acyclovir: A controlled trial. JAMA 251:2103, 1984
69. Strauss SE, Seidlin M, Takiff HE, et al: Double-blind comparison of weekly and daily regimens of oral acyclovir for suppression of recurrent genital herpes. Antiviral Res 6:151, 1986
70. Thin RN, Jeffries DJ, Taylor PK, et al: Recurrent genital herpes suppressed by oral acyclovir; A multicenter double-blind trial. J Antimicrob Chemother 16:219, 1985
71. Kaplowitz L, Baker D, et al: Prolonged continuous acyclovir treatment in normal adults with frequently recurring genital herpes simplex virus infections. JAMA 256:747-751, 1991
72. Douglas JM, Critchlow C, Benedetti J, et al: Prevention of recurrent genital herpes simplex virus infection with daily oral acyclovir: A double-blind trial. N Engl J Med 310:1551, 1984
73. Lossick JG, Whittington W, Nigidas S, et al: Sexual transmission patterns of primary genital herpes. (Abstract 44) Programme of the 6th International Meeting, International Society of STD Research, Brighton, England, 31 July-2 Aug, 1985, p 40
74. Dekker C, Ellis MN, McLakren C, et al: Acyclovir. J Antimicrob Chemo Ther 12, SB 137, 1983
75. Safrin S, Elbeik T, Phan L, et al: Correlation between response to acyclovir and foscarnet therapy and in vitro susceptibility result for isolates of herpes simplex virus from human immunodeficiency virus-infected patients. J Antimicrob Agents Chemother 38:1246-1250, 1994